Disadvantage Indices Deployed to Promote Equitable Allocation of COVID-19 Vaccines in the US: A Scoping Review of Differences and Similarities in Design

JAMA Health Forum. 2022 Jan 21;3(1):e214501. doi: 10.1001/jamahealthforum.2021.4501. eCollection 2022 Jan.

Authors

Tuhina Srivastava¹, Harald Schmidt², Emily Sadecki², Melanie L Kornides³

Affiliations

¹ Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
² Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
³ Department of Family and Community Health, School of Nursing, University of Pennsylvania, Philadelphia.

Abstract

This scoping review identifies the construction and defined purpose of disadvantage indices deployed during the initial COVID-19 vaccine rollout.

Copyright 2022 Srivastava T et al. JAMA Health Forum.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

COVID-19 Vaccines* / therapeutic use
COVID-19* / prevention & control
Humans

Substances

COVID-19 Vaccines